Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription Articles published in PLoS One Retrieve available abstracts of 64 articles: HTML format

Single Articles

January 2025
1. HUANG Z, Shen Y, Fan X, Guo Q, et al
   Correction: Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells.
   PLoS One. 2025;20:e0317018.
   PubMed     Abstract available
   
   
   
2. JAAFARI N, Kojabad AA, Shabestari RM, Safa M, et al
   Design and fabrication of novel microfluidic-based droplets for drug screening on a chronic myeloid leukemia cell line.
   PLoS One. 2025;20:e0315803.
   PubMed     Abstract available
   
   
   
3. HU Z, Ge A, Wang X, Ou C, et al
   Evaluation of the practical application of the category-imbalanced myeloid cell classification model.
   PLoS One. 2025;20:e0313277.
   PubMed     Abstract available
   
   
   
4. MATSUO M, Liu S, Yamada H, Takemasa E, et al
   Time-sensitive effects of quercetin on rat basophilic leukemia (RBL-2H3) cell responsiveness and intracellular signaling.
   PLoS One. 2025;20:e0319103.
   PubMed     Abstract available
   
   
   
5. LEIGH RS, Kaynak BL, Ruskoaho H, Valimaki MJ, et al
   Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach.
   PLoS One. 2025;20:e0320443.
   PubMed     Abstract available
   
   
   
6. ZHONG D, Liu Y, Mo L, Zhang L, et al
   Establishment and application of an intelligent management platform for home medication for children with leukemia.
   PLoS One. 2025;20:e0320790.
   PubMed     Abstract available
   
   
   
7. VAFAJOO M, Shahidi M, Shahriyary F, Amirzargar MR, et al
   Resveratrol decreases extracellular traps (ETs) in acute promyelocytic leukemia (NB4) cells.
   PLoS One. 2025;20:e0321221.
   PubMed     Abstract available
   
   
   
8. ZHAO C, Zhang Y, Huang L, Xiang J, et al
   PTPN21 inhibits cell apoptosis of acute lymphoblastic leukemia induced by chemotherapeutic agents via GADD45A and JNK signaling pathway.
   PLoS One. 2025;20:e0322273.
   PubMed     Abstract available
   
   
   
9. ALVAREZ-GOMEZ C, Fonseca-Benitez AV, Guevara-Pulido J
   Design, synthesis, and in vitro evaluation of a carbamazepine derivative with antitumor potential in a model of Acute Lymphoblastic Leukemia.
   PLoS One. 2025;20:e0319415.
   PubMed     Abstract available
   
   
   
10. JAN Z, Shabir M, Farman H, Rahman A, et al
    Deep learning based semantic segmentation of leukemia effected white blood cell.
    PLoS One. 2025;20:e0320596.
    PubMed     Abstract available
    
    
    
11. PARK H, Miyano S
    Network-based multi-class classifier to identify optimized gene networks for acute leukemia cell line classification.
    PLoS One. 2025;20:e0321549.
    PubMed     Abstract available
    
    
    
12. HOLOUBEK A, Strachotova D, Wolfova K, Otevrelova P, et al
    Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.
    PLoS One. 2025;20:e0322096.
    PubMed     Abstract available
    
    
    
13. WANG Z, Wang C, Zhang D, Wang X, et al
    The up-regulation of TGF-beta1 by miRNA-132-3p/WT1 is involved in inducing leukemia cells to differentiate into macrophages.
    PLoS One. 2025;20:e0306150.
    PubMed     Abstract available
    
    
    
14. GALLANT R, Reza S, Wiemels JL, Greaves M, et al
    Microbiome and pediatric leukemia, diabetes, and allergies: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0324167.
    PubMed     Abstract available
    
    
    
15. ILYAS M, Ramzan M, Deriche M, Mahmood K, et al
    An efficient leukemia prediction method using machine learning and deep learning with selected features.
    PLoS One. 2025;20:e0320669.
    PubMed     Abstract available
    
    
    
16. LI J, Wang S
    Integrative analysis of epigenetic subtypes in acute myeloid Leukemia: A multi-center study combining machine learning for prognostic and therapeutic insights.
    PLoS One. 2025;20:e0324380.
    PubMed     Abstract available
    
    
    
17. OURU PA, Zheng H, Lin Z, Yang M, et al
    A multicenter cross-sectional study on factors associated with caregiving appraisal in pediatric acute leukemia caregivers.
    PLoS One. 2025;20:e0324589.
    PubMed     Abstract available
    
    
    
18. KASSA E, Ayalew M, Birhan M, Gelaw A, et al
    Clinical profile and treatment outcomes of acute lymphoblastic leukemia among children attending at the University of Gondar comprehensive specialized hospital and Tikur Anbessa Specialized Hospital in Ethiopia.
    PLoS One. 2025;20:e0322747.
    PubMed     Abstract available
    
    
    
19. HOSSEN MA, Jahan UMS, Hossain MA, Asif KH, et al
    Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
    PLoS One. 2025;20:e0320550.
    PubMed     Abstract available
    
    
    
20. AHMAD W, Shahzad AR, Amin MA, Bangyal WH, et al
    Machine learning driven dashboard for chronic myeloid leukemia prediction using protein sequences.
    PLoS One. 2025;20:e0321761.
    PubMed     Abstract available
    
    
    
21. VRANA C, Zhang M, Rochette M, Alozie M, et al
    Efficacy of NAMPT inhibition in T-cell acute lymphoblastic leukemia.
    PLoS One. 2025;20:e0324443.
    PubMed     Abstract available
    
    
    
22. RADTKE V, Konig T, Radcke C, Bergmann U, et al
    Physicochemical quality assessment of four asparaginases.
    PLoS One. 2025;20:e0326106.
    PubMed     Abstract available
    
    
    
23. HU C, Chen W, Zhang P, Shen T, et al
    Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021.
    PLoS One. 2025;20:e0325937.
    PubMed     Abstract available
    
    
    
24. SASAROM M, Anuchapreeda S, Hennink WE, Okonogi S, et al
    Influence of capping agents on physicochemical properties and leukemic cytotoxicity of copper oxide nanoparticles biosynthesized using Caesalpinia sappan extract.
    PLoS One. 2025;20:e0326791.
    PubMed     Abstract available
    
    
    
25. SZYMCZYK A, Chocholska S, Radko K, Hus M, et al
    Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients - a single-center pilotal study.
    PLoS One. 2025;20:e0324320.
    PubMed     Abstract available
    
    
    
26. NAVIDINIA AA, Khayami R, Gholami A, Fathi M, et al
    Bioinformatics-guided construction of a tumor microenvironment-derived prognostic model in acute myeloid leukemia.
    PLoS One. 2025;20:e0325145.
    PubMed     Abstract available
    
    
    
27. BIEZUS G, Grima de Cristo T, Flores Koehler CM, de Quadros Kaveski FY, et al
    Survival analysis and clinical abnormalities in cats with progressive or regressive feline leukemia virus (FeLV) infection in Brazil.
    PLoS One. 2025;20:e0322691.
    PubMed     Abstract available
    
    
    January 2024
28. PALACIOS A, Espinola N, Gonzalez JM, Rojas-Roque C, et al
    Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina.
    PLoS One. 2024;19:e0295798.
    PubMed     Abstract available
    
    
    
29. HUANG T, Leung B, Huang Y, Price L, et al
    A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia.
    PLoS One. 2024;19:e0292375.
    PubMed     Abstract available
    
    
    
30. HIRASAWA I, Odagiri H, Park G, Sanghavi R, et al
    Correction: Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
    PLoS One. 2024;19:e0299329.
    PubMed     Abstract available
    
    
    
31. KANITTHAMNIYOM C, Wannaphut C, Pattanaprichakul P, Kungwankiattichi S, et al
    Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
    PLoS One. 2024;19:e0297805.
    PubMed     Abstract available
    
    
    
32. SWANSON AJ, Rogowski VJ, Bishop JA, Walker DM, et al
    CLEC11A methylation is correlated to AML subtypes and cytogenetic risk factors but not patient demographics.
    PLoS One. 2024;19:e0300477.
    PubMed     Abstract available
    
    
    
33. SUN K, Tian X, Xia J, Li Q, et al
    Promoting leisure functions through setting creative linguistic landscapes in recreational zones.
    PLoS One. 2024;19:e0299775.
    PubMed     Abstract available
    
    
    
34. 
    Retraction: Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.
    PLoS One. 2024;19:e0301946.
    PubMed    
    
    
    
35. MESSLING JE, Pena-Romer I, Moroni AS, Bruestl S, et al
    RIO-kinase 2 is essential for hematopoiesis.
    PLoS One. 2024;19:e0300623.
    PubMed     Abstract available
    
    
    
36. KNOPPERS T, Haley CE, Bouhouita-Guermech S, Hagan J, et al
    From code to care: Clinician and researcher perspectives on an optimal therapeutic web portal for acute myeloid leukemia.
    PLoS One. 2024;19:e0302156.
    PubMed     Abstract available
    
    
    
37. EISSENBERG LG, Ritchey JK, Rettig MP, Patel DA, et al
    Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
    PLoS One. 2024;19:e0300174.
    PubMed     Abstract available
    
    
    
38. MURAKAMI K, Matsunaga T, Matsuzaki T, Naruke Y, et al
    Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis.
    PLoS One. 2024;19:e0302868.
    PubMed     Abstract available
    
    
    
39. DONG L, Dai G, Zhao J
    Impact of body mass index at diagnosis on outcomes of pediatric acute leukemia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302879.
    PubMed     Abstract available
    
    
    
40. SUZUKI S, Suzuki S, Sato-Nagaoka Y, Ito C, et al
    Identification of triciribine as a novel myeloid cell differentiation inducer.
    PLoS One. 2024;19:e0303428.
    PubMed     Abstract available
    
    
    
41. HAN HJ, Choi K, Suh HS
    Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A real-world, population-based longitudinal cohort study.
    PLoS One. 2024;19:e0300637.
    PubMed     Abstract available
    
    
    
42. MOHAMMADIAN-HAFSHEJANI A, Farber IM, Kheiri S
    Global incidence and mortality of childhood leukemia and its relationship with the Human Development Index.
    PLoS One. 2024;19:e0304354.
    PubMed     Abstract available
    
    
    
43. TAUCHI T, Moriya S, Okabe S, Kazama H, et al
    Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
    PLoS One. 2024;19:e0307662.
    PubMed     Abstract available
    
    
    
44. GUO X, Zhang R, Liu J, Li M, et al
    Correction: Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
    PLoS One. 2024;19:e0307986.
    PubMed     Abstract available
    
    
    
45. ARNER A, Ettinger A, Blaser BW, Schmid B, et al
    In vivo monitoring of leukemia-niche interactions in a zebrafish xenograft model.
    PLoS One. 2024;19:e0309415.
    PubMed     Abstract available
    
    
    
46. SOLEIMANI Y, Daraei M, Sadeghi P, Khazali A, et al
    Wood dust and risk of leukemia: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0307444.
    PubMed     Abstract available
    
    
    
47. KANG KW, Gim JA, Hong S, Kim HK, et al
    Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers.
    PLoS One. 2024;19:e0306962.
    PubMed     Abstract available
    
    
    
48. LIM K, Kan WL, Nair PC, Kutyna M, et al
    CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
    PLoS One. 2024;19:e0310641.
    PubMed     Abstract available
    
    
    
49. OSADA N, Kikuchi J, Okada Y, Matsuoka S, et al
    Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells.
    PLoS One. 2024;19:e0309533.
    PubMed     Abstract available
    
    
    
50. AL-NAKHLE HH, Yagoub HS, Alrehaili RY, Shaqroon OA, et al
    Elucidating the role of MLL1 nsSNPs: Structural and functional alterations and their contribution to leukemia development.
    PLoS One. 2024;19:e0304986.
    PubMed     Abstract available
    
    
    
51. PANDIYAN A, Lari S, Vanka J, Kumar BS, et al
    Plasma pesticide residues-serum 8-OHdG among farmers/non-farmers diagnosed with lymphoma, leukaemia and breast cancers: A case-control study.
    PLoS One. 2024;19:e0295625.
    PubMed     Abstract available
    
    
    
52. SILVA MA, Williams S, Hauert S, Ovadia B, et al
    Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.
    PLoS One. 2024;19:e0313026.
    PubMed     Abstract available
    
    
    
53. 
    Correction: Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
    PLoS One. 2024;19:e0313701.
    PubMed     Abstract available
    
    
    
54. AN JB, Hathcock KS, Steinberg SM, Choo-Wosoba HM, et al
    ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival.
    PLoS One. 2024;19:e0312864.
    PubMed     Abstract available
    
    
    
55. 
    Correction: Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.
    PLoS One. 2024;19:e0315260.
    PubMed     Abstract available
    
    
    
56. NAGEL S, Meyer C, Pommerenke C
    IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia.
    PLoS One. 2024;19:e0315196.
    PubMed     Abstract available
    
    
    
57. TANG D, Wang H, Jiang Y, Chen M, et al
    ATRA-induced NEAT1 upregulation promotes autophagy during APL cell granulocytic differentiation.
    PLoS One. 2024;19:e0316109.
    PubMed     Abstract available
    
    
    
58. SATO-NAGAOKA Y, Suzuki S, Suzuki S, Takahashi S, et al
    Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells.
    PLoS One. 2024;19:e0312406.
    PubMed     Abstract available
    
    
    January 2023
59. HUANG Z, Shen Y, Fan X, Guo Q, et al
    Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells.
    PLoS One. 2023;18:e0289697.
    PubMed     Abstract available
    
    
    
60. ILYAS M, Aamir KM, Manzoor S, Deriche M, et al
    Linear programming based computational technique for leukemia classification using gene expression profile.
    PLoS One. 2023;18:e0292172.
    PubMed     Abstract available
    
    
    
61. HIRASAWA I, Odagiri H, Park G, Sanghavi R, et al
    Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
    PLoS One. 2023;18:e0292267.
    PubMed     Abstract available
    
    
    
62. POOPAK A, Saeedi Moghaddam S, Esfahani Z, Keykhaei M, et al
    National and subnational burden of leukemia and its risk factors, 1990-2019: Results from the Global Burden of Disease study 2019.
    PLoS One. 2023;18:e0287917.
    PubMed     Abstract available
    
    
    
63. WANG Y, Travers RJ, Farrell A, Lu Q, et al
    Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.
    PLoS One. 2023;18:e0294438.
    PubMed     Abstract available
    
    
    
64. SWAIN RM, Sanchez A, Gutierrez DA, Varela-Ramirez A, et al
    Thiophene derivative inflicts cytotoxicity via an intrinsic apoptotic pathway on human acute lymphoblastic leukemia cells.
    PLoS One. 2023;18:e0295441.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.